Search

Roche Holding AG

Deschisă

SectorSănătate

295 -1.99

Rezumat

Modificarea prețului

24h

Curent

Minim

291

Maxim

302.2

Indicatori cheie

By Trading Economics

Venit

6.3B

Vânzări

31B

P/E

Medie Sector

29.748

63.778

Randament dividend

3.1

Marjă de profit

20.347

Angajați

103,249

EBITDA

11B

Dividende

By Dow Jones

Randament dividend

Medie Sector

3.10%

2.39%

Statistici piață

By TradingEconomics

Capitalizare de piață

233B

Deschiderea anterioară

296.99

Închiderea anterioară

295

Sentimentul știrilor

By Acuity

48%

52%

176 / 386 Clasament în Healthcare

Roche Holding AG Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

12 mar. 2025, 09:23 UTC

Principalele dinamici ale pieței

Zealand Pharma Shares Leap After Weight-Loss Licensing Deal With Roche

30 ian. 2025, 09:36 UTC

Câștiguri

Roche Expects Growth to Continue This Year After Sales, Earnings Beat Forecasts -- Update

30 ian. 2025, 06:32 UTC

Câștiguri

Roche Expects Sales, Earnings Growth After Better-Than-Expected Results

26 nov. 2024, 15:27 UTC

Achiziții, Fuziuni, Preluări

Trending: Roche to Buy Poseida Therapeutics for Up to $1.5 Billion

31 mar. 2025, 09:31 UTC

Acțiuni populare

Stocks to Watch Monday: Nvidia, Tesla, Robinhood, Tokyo Electron -- WSJ

13 mar. 2025, 07:46 UTC

Market Talk

Roche's Zealand Pharma Deal Signals Commitment to Obesity Drug Market -- Market Talk

12 mar. 2025, 16:34 UTC

Top știri

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal -- Update

12 mar. 2025, 08:51 UTC

Market Talk

Roche's Multiple-Sclerosis Drug Sales Potential Fuels Rating Upgrade -- Market Talk

12 mar. 2025, 08:18 UTC

Market Talk

Roche's Obesity Deal With Zealand Pharma Makes Sense, Vontobel Says -- Market Talk

13 feb. 2025, 11:43 UTC

Market Talk

Roche's Growth Fueled by Key Drugs, Promising Pipeline -- Market Talk

30 ian. 2025, 07:56 UTC

Market Talk
Câștiguri

Roche Delivered Solid Results But Diagnostics' Profitability Disappoints -- Market Talk

30 ian. 2025, 06:04 UTC

Câștiguri

Roche Expects 2025 EPS Growth in High Single Digit Range at Constant Currency

30 ian. 2025, 06:04 UTC

Câștiguri

Roche Expects 2025 Sales Increase in Mid Single Digit Range at Constant Currency

30 ian. 2025, 06:04 UTC

Câștiguri

Roche Issues 2025 View

30 ian. 2025, 06:03 UTC

Câștiguri

Roche Raises Dividend to CHF9.70 Vs CHF9.60

30 ian. 2025, 06:03 UTC

Câștiguri

Roche 2024 Core Operating Profit CHF20.82B

30 ian. 2025, 06:03 UTC

Câștiguri

Roche 2024 Net Pft CHF9.19B

30 ian. 2025, 06:02 UTC

Câștiguri

Analysts Saw 2024 Core EPS at CHF18.59

30 ian. 2025, 06:02 UTC

Câștiguri

Roche 2024 Core EPS CHF18.80

30 ian. 2025, 06:02 UTC

Câștiguri

Roche 2024 Sales EUR60.50B

30 ian. 2025, 06:02 UTC

Câștiguri

Analysts Saw Roche 2024 Revenue at CHF60.41B

30 ian. 2025, 06:01 UTC

Câștiguri

Roche 2024 Sales CHFB

28 ian. 2025, 10:30 UTC

Top știri

Drug Companies Raise Prices on More Than 800 Drugs in January -- WSJ

28 ian. 2025, 07:24 UTC

Market Talk

Roche's Breast Cancer Drug Extends Life of Patients -- Market Talk

15 ian. 2025, 10:22 UTC

Market Talk

Swiss Companies Pay Record Level of Dividends as Buybacks Fall -- Market Talk

8 ian. 2025, 06:15 UTC

Achiziții, Fuziuni, Preluări

Roche: 66.11% of Poseida's Shares Were Validly Tendered in Offer

8 ian. 2025, 06:12 UTC

Achiziții, Fuziuni, Preluări

Roche Intends to Complete Acquisition of Poseida Therapeutics Later Wednesday

16 dec. 2024, 22:03 UTC

Top știri

Novo's New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way. -- Barrons.com

13 dec. 2024, 16:36 UTC

Market Talk

Swiss Equities an Overweight Pick Next Year -- Market Talk

26 nov. 2024, 16:10 UTC

Achiziții, Fuziuni, Preluări

Why This Gene-Therapy Company's Stock Is Rising 228% -- Barrons.com

Roche Holding AG Așteptări

Sentiment

By Acuity

176 / 386 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.